2269 — Meiji Holdings Share News
0.000.00%
To Build New Yogurt Plant In Kanagawa, Japan, Investing About 40 Billion Yen
Table: Meiji HD -Q1 group results
Announces Result Of Share Buyback For May 14-31
To Buy Back Up To 3.94% Of Shares Worth 30 Billion Yen
Table: Meiji HD -2023/24 parent results
Table: Meiji HD -2023/24 group results
Table: Meiji HD -2023/24 group forecast
Notice Concerning Positive Results Of Phase III Study Of Bivalent Version Of Kostaive, Self-Amplifying MRNA Vaccine Against Covid-19
Table: Meiji HD - 9-MTH group results
Notice Concerning Capital Increase Of Sub-Subsidiary (To Be A Designated Subsidiary) To Invest In Production Capacity Of Tablet Baby Formula Products
Notice Concerning The Initiation Of Pediatric Phase Iii Clinical Trial Of Kd-414, A Covid-19 Vaccine Effective Against Mutant Strains
Kostaivetm, Self-Amplifying Mrna Vaccine Against Covid-19, Approved For Manufacturing And Marketing From Mhlw In Japan
Meiji Holdings recalls milk after detecting cattle drug
Table: Meiji HD - 6-MTH group results
2023 6-month group forecast
Table: Meiji HD -2023/24 group forecast
Brief: Meiji Holdings - Notice Concerning Submission Of Clinical Trial Notification For Pediatric Phase Iii Of Kd-414, A Covid-19 Vaccine Effective Against Mutant Strains
Notice Concerning Adoption As"Developing Biopharmaceutical Manufacturing Sites To Strengthen Vaccine Production Project"Offered By Meti
Table: Meiji HD -Q1 group results